Figure 1E is a histogram plot of HER2 expression measured by flow cytometry of a representative tumor compared to the HER2+ breast cancer cell line SKBR3 (DAKO test score 3+) and the HER2− breast cancer cell line MDA-MB-231 (DAKO test score 0). This evidence concerns the gene ERBB2 and breast cancer.